Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tris (dibenzylideneacetone) dipalladium: a small-molecule palladium complex is effective in inducing apoptosis in chronic lymphocytic leukemia B-cells
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 57, Issue 10, Pages 2409-2416
Publisher
Informa UK Limited
Online
2016-05-18
DOI
10.3109/10428194.2016.1161186
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors
- (2015) S. Sinha et al. CLINICAL CANCER RESEARCH
- Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia
- (2015) F. Cervantes-Gomez et al. CLINICAL CANCER RESEARCH
- Tris DBA palladium overcomes hypoxia-mediated drug resistance in multiple myeloma
- (2015) Pilar de la Puente et al. LEUKEMIA & LYMPHOMA
- MCL-1 and BCL-xL-dependent resistance to the BCL-2 inhibitor ABT-199 can be overcome by preventing PI3K/AKT/mTOR activation in lymphoid malignancies
- (2015) G S Choudhary et al. Cell Death & Disease
- Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells
- (2014) U. Rozovski et al. BLOOD
- Activation of the PI3K/AKT pathway by microRNA-22 results in CLL B-cell proliferation
- (2014) F Palacios et al. LEUKEMIA
- STAT3-Activated GM-CSFR Translocates to the Nucleus and Protects CLL Cells from Apoptosis
- (2014) P. Li et al. MOLECULAR CANCER RESEARCH
- Valproic acid enhances fludarabine-induced apoptosis mediated by ROS and involving decreased AKT and ATM activation in B-cell-lymphoid neoplastic cells
- (2013) Ju-Yoon Yoon et al. APOPTOSIS
- Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis
- (2013) Wei Ding et al. BRITISH JOURNAL OF HAEMATOLOGY
- The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways
- (2013) Juraj Bodo et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ribosomal Protein S6, a Target of Rapamycin, Is Involved in the Regulation of rRNA Genes by Possible Epigenetic Changes inArabidopsis
- (2013) Yun-Kyoung Kim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activity
- (2013) S Cheng et al. LEUKEMIA
- The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients
- (2013) J Boysen et al. LEUKEMIA
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- The PI3-Kinase Delta Inhibitor Idelalisib (GS-1101) Targets Integrin-Mediated Adhesion of Chronic Lymphocytic Leukemia (CLL) Cell to Endothelial and Marrow Stromal Cells
- (2013) Stefania Fiorcari et al. PLoS One
- Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT
- (2012) R. Negro et al. BLOOD
- Prognostic significance and function of phosphorylated ribosomal protein S6 in esophageal squamous cell carcinoma
- (2012) Seok-Hyung Kim et al. MODERN PATHOLOGY
- Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks
- (2011) Brian Magnuson et al. BIOCHEMICAL JOURNAL
- The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy
- (2010) A. K. Ghosh et al. BLOOD
- STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells
- (2010) I. Hazan-Halevy et al. BLOOD
- Platelet-derived growth factor (PDGF)-PDGF receptor interaction activates bone marrow-derived mesenchymal stromal cells derived from chronic lymphocytic leukemia: implications for an angiogenic switch
- (2010) W. Ding et al. BLOOD
- ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats
- (2010) L.Y. Hu et al. NEUROSCIENCE
- Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells
- (2009) A. K. Ghosh et al. BLOOD
- Curcumin Inhibits Prosurvival Pathways in Chronic Lymphocytic Leukemia B Cells and May Overcome Their Stromal Protection in Combination with EGCG
- (2009) A. K. Ghosh et al. CLINICAL CANCER RESEARCH
- Regulation of ribosomal protein S6 kinases by ubiquitination
- (2008) Mong-Lien Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Tris (Dibenzylideneacetone) Dipalladium, a N-Myristoyltransferase-1 Inhibitor, Is Effective against Melanoma Growth In vitro and In vivo
- (2008) S. S. Bhandarkar et al. CLINICAL CANCER RESEARCH
- Regulation and localization of ribosomal protein S6 kinase 1 isoforms
- (2008) Doyil Kim et al. GROWTH FACTORS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started